Remarkable shrinkage of sarcomatoid renal cell carcinoma with single-agent gemcitabine

Anti-Cancer Drugs

Volumn 19, Issue 4, 2008, Pages 431-433

  Fujiwara, Yoshiro ^a   Kiura, Katsuyuki ^a,b   Tabata, Masahiro ^b   Takigawa, Nagio ^b   Hotta, Katsuyuki ^a   Umemura, Shigeki ^a   Omori, Masako ^c   Gemba, Kenichi ^d   Ueoka, Hiroshi ^e   Tanimoto, Mitsune ^a,b  

^a OKAYAMA UNIVERSITY   (Japan)

^b Departments of Respiratory Medicine   (Japan)

^c OKAYAMA UNIVERSITY HOSPITAL   (Japan)

^d OKAYAMA ROSAI HOSPITAL   (Japan)

^e NATIONAL SANYO HOSPITAL   (Japan)

Author keywords

Gemcitabine; Poor performance status; Sarcomatoid renal cell carcinoma

Indexed keywords

CALCIUM; CYTOKERATIN; GEMCITABINE; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CASE REPORT; CAUSE OF DEATH; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; CONSCIOUSNESS; CRITICALLY ILL PATIENT; DRUG TOLERABILITY; GLUTEUS MAXIMUS MUSCLE; HIP PAIN; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; IMMUNOHISTOCHEMISTRY; JAPANESE; KIDNEY BIOPSY; KIDNEY CARCINOMA; KIDNEY SARCOMA; LABORATORY TEST; LEUKOCYTE COUNT; LUNG METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; MUSCLE METASTASIS; POOR GENERAL CONDITION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SARCOMATOID RENAL CELL CARCINOMA; TREATMENT OUTCOME; TUMOR BIOPSY; UNSPECIFIED SIDE EFFECT; BUTTOCK; KIDNEY TUMOR; LUNG TUMOR; METASTASIS; MIDDLE AGED; MUSCLE TUMOR; PATHOLOGY; RADIOGRAPHY;

ANTIMETABOLITES, ANTINEOPLASTIC; BUTTOCKS; CARCINOMA, RENAL CELL; DEOXYCYTIDINE; HUMANS; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUSCLE NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 47949086939     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/CAD.0b013e3282f5d336     Document Type: Article

References (16)

1. Kuroda N, Toi M, Hiroi M, Enzan H. Review of sarcomatoid renal Cell carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 2003; 18:551-555.
2. Mian BM, Bhadkamkar N, Slaton JW, Pisters PW, Daliani D, Swanson DA, et al. Prognostic factors and survival of patients with sarcomatoid renal Cell carcinoma. J Urol 2002; 167:65-70.
3. Mertens WC, Eisenhauer EA, Moore M, Venner P, Stewart D, Muldal A, et al. Gemcitabine in advanced renal Cell carcinoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group. Ann Oncol 1993; 4:331-332.
4. De Mulder PH, Weissbach L, Jakse G, Osieka R, Blatter J. Gemcitabine: a phase II study in patients with advanced renal cancer. Cancer Chemother Pharmacol 1996; 37:491-495.
5. Bergman AM, Pinedo HM, Talianidis I, Veerman G, Loves WJ, van der Wilt CL, et al. Increased sensitivity to gemcitabine of P-glycoprotein and multidrug resistance-associated protein-overexpressing human cancer Cell lines. Br J Cancer 2003; 88:1963-1970.
6. Hartmann JT, Patel S. Recent developments in salvage chemotherapy for patients with metastatic soft tissue sarcoma. Drugs 2005; 65:167-178.
7. Green MR. Gemcitabine safety overview. Semin Oncol 1996; 23 (5 Suppl 10):32-35.
8. Avery AK, Beckstead J, Renshaw AA, Corless CL. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol 2000; 24:203-210.
9. Culine S, Bekradda M, Terrier-Lacombe MJ, Droz JP. Treatment of sarcomatoid renal Cell carcinoma: is there a role for chemotherapy? Eur Urol 1995; 27:138-141.
10. Sella A, Logothetis CJ, Ro JY, Swanson DA, Samuels ML. Sarcomatoid renal Cell carcinoma. A treatable entity. Cancer 1987; 60:1313-1318.
11. Ferrigno D, Buccheri G. Front-line weekly chemotherapy with gemcitabine for unfit patients with non-small Cell lung cancer (NSCLC). Lung Cancer 2004; 45:373-380.
12. Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 2007; 356:115-124.
13. Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, et al. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 2007; 356:125-134.
14. Hiraki A, Ueoka H, Takata I, Gemba K, Bessho A, Segawa Y, et al. Hypercalcemia-leukocytosis syndrome associated with lung cancer. Lung Cancer 2004; 43:301-307.
15. Schatteman P, Willemsen P, Vanderveken M, Lockefeer F, Vandebroek A. Skeletal muscle metastasis from a conventional renal Cell carcinoma, two years after nephrectomy: a case report. Acta Chir Belg 2002; 102:351-352.
16. Lemay M, Piro AJ. Cavitary pulmonary metastases. Ann Intern Med 1965; 62:59-66.